Steven Cohen's CME Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 112,620 shares of CME Group Inc. (CME) worth $30.75 M, representing 0.03% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 47 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in CME, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2019, adding 372,501 shares. Largest reduction occurred in Q2 2019, reducing 347,658 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +97,620 | Add 650.80% | 112,620 | $273.08 |
| Q3 2025 | -64,556 | Reduce 81.15% | 15,000 | $270.19 |
| Q2 2025 | -110,755 | Reduce 58.20% | 79,556 | $275.62 |
| Q1 2025 | +175,311 | Add 1168.74% | 190,311 | $265.29 |
| Q4 2024 | -83,175 | Reduce 84.72% | 15,000 | $232.23 |
| Q3 2024 | -117,360 | Reduce 54.45% | 98,175 | $220.65 |
| Q2 2024 | +140,503 | Add 187.26% | 215,535 | $196.60 |
| Q4 2023 | -1,170 | Reduce 1.54% | 75,032 | $210.60 |
| Q3 2023 | -85,600 | Reduce 52.90% | 76,202 | $200.22 |
| Q2 2023 | -45,207 | Reduce 21.84% | 161,802 | $185.29 |
| Q1 2023 | +122,311 | Add 144.41% | 207,009 | $191.52 |
| Q4 2022 | +2,319 | Add 2.82% | 84,698 | $168.16 |
| Q3 2022 | -35,512 | Reduce 30.12% | 82,379 | $177.13 |
| Q2 2022 | +51,648 | Add 77.97% | 117,891 | $204.70 |
| Q1 2022 | +6,211 | Add 10.35% | 66,243 | $237.87 |
| Q4 2021 | -63,600 | Reduce 51.44% | 60,032 | $228.46 |
| Q3 2021 | +63,600 | Add 105.94% | 123,632 | $193.38 |
| Q3 2019 | -24,843 | Reduce 29.27% | 60,032 | $211.34 |
| Q2 2019 | -347,658 | Reduce 80.38% | 84,875 | $194.11 |
| Q1 2019 | +372,501 | Add 620.50% | 432,533 | $164.58 |
| Q3 2018 | -8,100 | Reduce 11.89% | 60,032 | $170.21 |
| Q2 2018 | -231,626 | Reduce 77.27% | 68,132 | $163.92 |
| Q1 2018 | +239,726 | Add 399.33% | 299,758 | $161.74 |
| Q1 2017 | -231,900 | Reduce 79.44% | 60,032 | $118.80 |
| Q4 2016 | +231,900 | Add 386.29% | 291,932 | $115.35 |
| Q2 2016 | +15,000 | Add 33.31% | 60,032 | $97.40 |
| Q4 2015 | +15,000 | Add 49.95% | 45,032 | $90.60 |
| Q2 2014 | +30,032 | Add 0.00% | 30,032 | $70.96 |
Steven Cohen's CME Group Investment FAQs
Steven Cohen first purchased CME Group Inc. (CME) in Q2 2014, acquiring 30,032 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held CME Group Inc. (CME) for 47 quarters since Q2 2014.
Steven Cohen's largest addition to CME Group Inc. (CME) was in Q1 2019, adding 432,533 shares worth $71.19 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 112,620 shares of CME Group Inc. (CME), valued at approximately $30.75 M.
As of the Q4 2025 filing, CME Group Inc. (CME) represents approximately 0.03% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in CME Group Inc. (CME) was 432,533 shares, as reported at the end of Q1 2019.